CoChat

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission.

Van Damme, Lut, Govinden, Roshini, Mirembe, Florence M., Guédou, Fernand, Solomon, Suniti, Becker, Marissa L., Pradeep, B.S., Krishnan, A.K., Alary, Michel, Pande, Bina, Ramjee, Gita, Deese, Jennifer, Crucitti, Tania, Taylor, Doug · 2008 · New England Journal of Medicine

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Women make up more than 50% of adults living with human immunodeficiency virus (HIV) infection or the acquired immunodeficiency syndrome (AIDS) in sub-Saharan Africa. Thus, female-initiated HIV prevention methods are urgently needed. METHODS: We performed a randomized, double-blind, placebo-controlled trial of cellulose sulfate, an HIV-entry inhibitor formulated as a vaginal gel, involving women at high risk for HIV infection at three African and two Indian sites. The primary end point was newly acquired infection with HIV type 1 or 2. The secondary end point was newly acquired gonococcal or chlamydial infection. The primary analysis was based on a log-rank test of no difference in the distribution of time to HIV infection, stratified according to site. RESULTS: A total of 1398 women were enrolled and randomly assigned to receive cellulose sulfate gel (706 participants) or placebo (692 participants) and had follow-up HIV test data. There were 41 newly acquired HIV infections, 25 in the cellulose sulfate group and 16 in the placebo group, with an estimated hazard ratio of infection for the cellulose sulfate group of 1.61 (P=0.13). This result, which is not significant, is in contrast to the interim finding that led to the trial being stopped prematurely (hazard ratio, 2.02 [corrected]; P=0.05 [corrected]) and the suggestive result of a preplanned secondary (adherence-based) analysis (hazard ratio, 2.02; P=0.05). No significant effect of cellulose sulfate as compared with placebo was found on the risk of gonorrheal infection (hazard ratio, 1.10; 95% confidence interval [CI], 0.74 to 1.62) or chlamydial infection (hazard ratio, 0.71; 95% CI, 0.47 to 1.08). CONCLUSIONS: Cellulose sulfate did not prevent HIV infection and may have increased the risk of HIV acquisition. (ClinicalTrials.gov number, NCT00153777; and Current Controlled Trials number, ISRCTN95638385.)

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa0707957

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. Saifuddin M, Doncel GF, Tsai L, Gettie A, Bhom R, Cheng-Mayer C. Intravaginal administration of 6% cellulose sulfate gel prevented systemic infection in rhesus macaques in a multiple dose R5/X4 SHIV vaginal challenge model. Presented at the Late Breaker Session, Microbicides 2008 Conference, Delhi, India, February 24–27, 2008.
  2. Johansson E. Results of phase III Carraguard trial. Presented at the Microbicides 2008 Conference, Delhi, India, February 24–27, 2008.
  3. Halpern V, Wang L, Obunge O, et al. Effectiveness of cellulose sulfate gel for prevention of HIV: results of the phase III trial in Nigeria. Presented at the Late Breaker Session of the 4th IAS Conference on HIV Pathogenesis, Treatment and Prevention, Sydney, July 22–25, 2007.
  4. Celum C, Wald A, Hughes J, et al. HSV-2 suppressive therapy for prevention of HIV acquisition: results of HPTN 039. Presented at the 15th Conference on Retroviruses and Opportunistic Infections, Boston, February 3–6, 2008.

Cited by

See all 438

Metadata

Authors
Van Damme, L., Govinden, R., Mirembe, F. M., Guédou, F., Solomon, S., Becker, M. L., Pradeep, B. S., Krishnan, A. K., Alary, M., Pande, B., Ramjee, G., Deese, J., Crucitti, T., & Taylor, D.
Affiliations
  • South African Medical Research Council (ZA)
  • Makerere University (UG)
  • Centre hospitalier affilié universitaire de Québec (CA)
  • University of Manitoba (CA)
  • St.John's Medical College Hospital (IN)
  • Family Health International 360 (US)
  • Instituut voor Tropische Geneeskunde (BE)
Venue
New England Journal of Medicine
Published
2008-07-31
Volume
359
Issue
5
Pages
463-472
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1994566416
Cited by
438
References
23
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 6 · 2022: 4 · 2021: 16 · 2020: 15 · 2019: 7 · 2018: 8 · 2017: 12 · 2016: 19 · 2015: 26 · 2014: 30 · 2013: 49 · 2012: 59
FWCI
38.35
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
Keywords
cellulose sulfate, vaginal gel, HIV prevention, HIV entry inhibitors, gonorrhea, chlamydia, sub-Saharan Africa, India
MeSH terms
Administration, Intravaginal, Adult, Cellulose, Chlamydia Infections, Double-Blind Method, Female, Gels, Gonorrhea, Humans, Placebos, Sexual Behavior, HIV Infections, Treatment Failure, Disease Transmission, Infectious, Anti-HIV Agents, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.